ICICI Lombard Q1 FY27 Results Analysis: PAT Down 46%, Combined Ratio Worsens to 107.2% (ICICIGI)

CompoundingAI Research Updated July 15, 2026 2 min read
Negative

ICICI Lombard General Insurance Company Ltd's Q1 FY27 numbers came in soft, with revenue of Rs. 6,813.71 Cr (+12.00% YoY) and PAT growth of -46.00% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateJuly 16, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 6,813.71 Cr (+12.00% YoY)
PAT (Q1)Rs. 403.17 Cr (-46.00% YoY)
EPS (Q1)Rs. 8.08 (-46.30% YoY)
Market capRs. 90,600.76 Cr
CMPRs. 1,814.60

Quarter Snapshot

ICICI Lombard reported a weak Q1 with PAT down 46% YoY and combined ratio worsening to 107.2%, primarily due to a Rs.16,500 Lakh reserve from the Supreme Court ruling on Motor TP claims. While Health Retail emerged as a bright spot with 50.2% premium growth and a swing to profitability, the overall underwriting loss widened sharply, and the near-term outlook hinges on the review petition and potential tariff relief.

Key Investment Insights

Key Positives

  • Health Retail premium grew 50.2% YoY and turned to operating profit of Rs.3,388 Lakh from a loss of Rs.8,456 Lakh.
  • Net Premium Written grew 17.7% YoY, indicating higher retention.
  • Solvency ratio improved to 2.71x from 2.67x at FY26.
  • Fair Value Change Account turned positive to Rs.7,220 Lakh from negative Rs.73,548 Lakh, adding Rs.80,768 Lakh to shareholders' funds.
  • Crop segment turned to underwriting profit of Rs.521 Lakh from a loss of Rs.413 Lakh.

Risk Factors

  • PAT declined 46.0% YoY to Rs.40,317 Lakh, driven by underwriting loss.
  • Combined ratio deteriorated 430 bps YoY to 107.2% from 102.9%.
  • Underwriting loss widened 115% YoY to Rs.62,988 Lakh.
  • Motor underwriting loss widened 131% YoY to Rs.24,521 Lakh, primarily due to Supreme Court judgment claim reserve of Rs.16,500 Lakh.
  • Health Group/Corporate underwriting loss exploded 193% YoY to Rs.30,173 Lakh.
  • Commission expense grew 32.9% YoY, outpacing premium growth and squeezing margins.
  • Total expenses grew 21.2% vs revenue growth of 12.0%, a 920 bps gap indicating margin compression.
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings

Login Now